Showing results (61-70 of 75) with videos related to

Sort By:
Pageof 8
Theranostics|January 4, 2021
CXCR4 PET imaging of mantle cell lymphoma using [68Ga]Pentixafor: comparison with [18F]FDG-PETMarius E Mayerhoefer, Markus Raderer, Wolfgang Lamm, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 18, 2023
A phase I/II study of the safety and efficacy of [177Lu]Lu-satoreotide tetraxetan in advanced somatostatin receptor-positive neuroendocrine tumoursDamian Wild, Henning Grønbæk, Shaunak Navalkissoor, et al.
Cardiovascular and Interventional Radiology|March 25, 2011
Transarterial hepatic yttrium-90 radioembolization in patients with unresectable intrahepatic cholangiocarcinoma: factors associated with prolonged survivalRalf-T Hoffmann, Philipp M Paprottka, Agnes Schön, et al.
Cancers|April 3, 2021
Breast Tumor Characterization Using [18F]FDG-PET/CT Imaging Combined with Data Preprocessing and RadiomicsDenis Krajnc, Laszlo Papp, Thomas S Nakuz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|February 27, 2018
Ultra-early response assessment in lymphoma treatment: [18F]FDG PET/MR captures changes in glucose metabolism and cell density within the first 72 hours of treatmentMarius E Mayerhoefer, Markus Raderer, Ulrich Jaeger, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|August 25, 2012
Peptide receptor radionuclide therapy for neuroendocrine tumors in Germany: first results of a multi-institutional cancer registryDieter Hörsch, Samer Ezziddin, Alexander Haug, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 30, 2019
Multiparametric 18F-FDG PET/MRI of the Breast: Are There Differences in Imaging Biomarkers of Contralateral Healthy Tissue Between Patients With and Without Breast Cancer?Doris Leithner, Thomas H Helbich, Blanca Bernard-Davila, et al.
The Lancet. Digital Health|December 22, 2023
Deep learning for [18F]fluorodeoxyglucose-PET-CT classification in patients with lymphoma: a dual-centre retrospective analysisIda Häggström, Doris Leithner, Jennifer Alvén, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 26, 2024
Dosimetry and pharmacokinetics of [177Lu]Lu-satoreotide tetraxetan in patients with progressive neuroendocrine tumoursSeval Beykan Schürrle, Uta Eberlein, Catherine Ansquer, et al.
Nuklearmedizin. Nuclear Medicine|January 8, 2024
CXCR4-targeted Theranostics in Hematooncology: Opportunities and ChallengesRudolf Werner, Alexander Haug, Christian Buske, et al.
Pageof 8